Brief: Acadia Pharmaceuticals Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference
Jan 14 (Reuters) - ACADIA Pharmaceuticals Inc ACAD.O :
* ACADIA PHARMACEUTICALS PROVIDES BUSINESS AND PIPELINE
UPDATES AT
43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
* ACADIA PHARMACEUTICALS INC: ANNUAL NET SALES FOR FULL-YEAR
2025
EXPECTED TO EXCEED $1 BILLION
* ACADIA PHARMACEUTICALS: MARKETING AUTHORIZATION
APPLICATION FOR
DAYBUE SUBMITTED TO EMA
Source text: ID:nBw9YXYGNa
Further company coverage: ACAD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry